As for pre-operative molecular diagnosis of gliomas, IDH mutation can be well recognized by identification of 2-HG on 7.0 Tesla magnetic resonance spectroscopy (MRS) [10]. The gene discussed is IDH1; the disease is central nervous system cancer.